NASDAQ:CYRX Cryoport - CYRX Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cryoport, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $25.24 -0.62 (-2.40%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$24.98▼$26.0150-Day Range$15.97▼$25.8652-Week Range$15.63▼$45.36Volume394,049 shsAverage Volume469,868 shsMarket Capitalization$1.24 billionP/E RatioN/ADividend YieldN/APrice Target$40.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Cryoport MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside60.5% Upside$40.50 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.64Based on 3 Articles This WeekInsider TradingSelling Shares$142,318 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.89) to ($0.63) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.10 out of 5 starsTransportation Sector69th out of 121 stocksPharmaceutical Preparations Industry248th out of 501 stocks 3.5 Analyst's Opinion Consensus RatingCryoport has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $40.50, Cryoport has a forecasted upside of 60.5% from its current price of $25.24.Amount of Analyst CoverageCryoport has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for CYRX. Previous Next 0.0 Dividend Strength Dividend YieldCryoport does not currently pay a dividend.Dividend GrowthCryoport does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CYRX. Previous Next 2.6 News and Social Media Coverage News SentimentCryoport has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Transportation companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cryoport this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 2 people have added Cryoport to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cryoport insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $142,318.00 in company stock.Percentage Held by InsidersOnly 9.70% of the stock of Cryoport is held by insiders.Percentage Held by Institutions88.66% of the stock of Cryoport is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cryoport are expected to grow in the coming year, from ($0.89) to ($0.63) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryoport is -4.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryoport is -4.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCryoport has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cryoport (NASDAQ:CYRX) StockCryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.Read More Receive CYRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter. Email Address CYRX Stock News HeadlinesJanuary 29, 2023 | finance.yahoo.comWhen Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable?January 27, 2023 | americanbankingnews.comCryoport (NASDAQ:CYRX) Shares Down 6.2% February 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 18, 2023 | finance.yahoo.comCryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene TherapiesDecember 23, 2022 | seekingalpha.comMadrigal Pharmaceuticals: Upcoming Windfall ProfitsDecember 20, 2022 | finance.yahoo.comCryoport to Present at the J.P. Morgan 41st Annual Healthcare ConferenceDecember 19, 2022 | finance.yahoo.comCryoport (NASDAQ:CYRX) shareholders have earned a 15% CAGR over the last five yearsDecember 17, 2022 | finance.yahoo.comCryoport, Inc. (CYRX) Stock Historical Prices & Data - Yahoo FinanceFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 10, 2022 | markets.businessinsider.com5 Analysts Have This to Say About CryoPortDecember 10, 2022 | msn.comExpert Ratings for CryoPortNovember 8, 2022 | finance.yahoo.comCryoport Third Quarter 2022 Earnings: Misses ExpectationsNovember 7, 2022 | finance.yahoo.comSome Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Made A Major Cut To Next Year's EstimatesNovember 4, 2022 | finance.yahoo.comCryoport Reports Results for the Third Quarter 2022November 4, 2022 | finance.yahoo.comCryoPort, Inc. (CYRX) Reports Q3 Loss, Misses Revenue EstimatesOctober 27, 2022 | finance.yahoo.comCryoPort, Inc. (CYRX) Stock Jumps 10.5%: Will It Continue to Soar?October 27, 2022 | finance.yahoo.comCryoport to Report Third Quarter 2022 Financial Results on November 3, 2022September 22, 2022 | seekingalpha.comCryoport: A Rare Investing Opportunity (NASDAQ:CYRX) - Seeking AlphaSeptember 18, 2022 | reuters.comCYRX.OQ - CryoPort Inc | Stock Price & Latest News | ReutersSeptember 17, 2022 | reuters.comCYRX.PH - CryoPort Inc | Stock Price & Latest News | ReutersSeptember 16, 2022 | nasdaq.comNoteworthy Friday Option Activity: JBI, NGM, CYRX - NasdaqSeptember 8, 2022 | finance.yahoo.comCryoport Enters into Strategic Relationship with Takeda's BioLife Plasma ServicesSeptember 4, 2022 | nasdaq.comNotable Friday Option Activity: AMD, CYRX, SQAugust 30, 2022 | nasdaq.comCryoport, Inc. (NASDAQ:CYRX) stock was sold by a number of insiders in the recent year, which isn't a positive indicator for investors - NasdaqAugust 24, 2022 | msn.comCryoPort Earnings Perspective: Return On Capital EmployedAugust 15, 2022 | thestreet.comBeaten-Down by GameStop Stock, Melvin Capital is Now Under SEC Scrutiny - TheStreetAugust 9, 2022 | fortune.comA new investigation throws private equity’s foothold in the autism services industry into question - FortuneSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CYRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter. Email Address CYRX Company Calendar Last Earnings11/04/2021Today2/05/2023Next Earnings (Estimated)2/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorTransportation Current SymbolNASDAQ:CYRX CUSIPN/A CIK1124524 Webwww.cryoport.com Phone(949) 470-2300Fax949-470-2306Employees791Year FoundedN/APrice Target and Rating Average Stock Price Forecast$40.50 High Stock Price Forecast$67.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+60.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($6.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-275,530,000.00 Net Margins-123.41% Pretax Margin-123.46% Return on Equity-14.84% Return on Assets-8.06% Debt Debt-to-Equity Ratio0.75 Current Ratio14.96 Quick Ratio14.35 Sales & Book Value Annual Sales$222.61 million Price / Sales5.56 Cash FlowN/A Price / Cash FlowN/A Book Value$13.64 per share Price / Book1.85Miscellaneous Outstanding Shares49,000,000Free Float44,247,000Market Cap$1.24 billion OptionableOptionable Beta1.32 Key ExecutivesJerrell W. SheltonChairman, President & Chief Executive OfficerRobert S. StefanovichChief Financial Officer, Secretary & TreasurerMark W. SawickiChief Scientific OfficerThomas J. HeinzenVice President-Corporate DevelopmentKey CompetitorsSun Country AirlinesNASDAQ:SNCYTeekay TankersNYSE:TNKSkyWestNASDAQ:SKYWGreenbrier CompaniesNYSE:GBXNavigatorNYSE:NVGSView All CompetitorsInsiders & InstitutionsEssex Investment Management Co. LLCSold 445 shares on 2/3/2023Ownership: 0.125%U S Global Investors Inc.Bought 8,500 shares on 2/3/2023Ownership: 0.017%Dfpg Investments LLCBought 11,635 shares on 2/2/2023Ownership: 0.024%SG Americas Securities LLCSold 7,318 shares on 2/2/2023Ownership: 0.012%Zurcher Kantonalbank Zurich Cantonalbank Bought 517 shares on 2/1/2023Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions CYRX Stock - Frequently Asked Questions Should I buy or sell Cryoport stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares. View CYRX analyst ratings or view top-rated stocks. What is Cryoport's stock price forecast for 2023? 4 Wall Street analysts have issued 1 year price targets for Cryoport's stock. Their CYRX share price forecasts range from $28.00 to $67.00. On average, they expect the company's stock price to reach $40.50 in the next year. This suggests a possible upside of 60.5% from the stock's current price. View analysts price targets for CYRX or view top-rated stocks among Wall Street analysts. How have CYRX shares performed in 2023? Cryoport's stock was trading at $17.35 at the start of the year. Since then, CYRX shares have increased by 45.5% and is now trading at $25.24. View the best growth stocks for 2023 here. When is Cryoport's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023. View our CYRX earnings forecast. How were Cryoport's earnings last quarter? Cryoport, Inc. (NASDAQ:CYRX) announced its quarterly earnings results on Thursday, November, 4th. The consumer goods maker reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.15) by $0.03. The consumer goods maker had revenue of $56.69 million for the quarter, compared to analyst estimates of $54.44 million. Cryoport had a negative net margin of 123.41% and a negative trailing twelve-month return on equity of 14.84%. The company's revenue was up 407.5% on a year-over-year basis. During the same period in the previous year, the company posted ($0.29) earnings per share. What guidance has Cryoport issued on next quarter's earnings? Cryoport issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $232.00 million-$238.00 million, compared to the consensus revenue estimate of $260.68 million. What other stocks do shareholders of Cryoport own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ). What is Cryoport's stock symbol? Cryoport trades on the NASDAQ under the ticker symbol "CYRX." Who are Cryoport's major shareholders? Cryoport's stock is owned by a variety of retail and institutional investors. Top institutional investors include New York State Common Retirement Fund (2.43%), Redwood Investments LLC (1.04%), Moody Aldrich Partners LLC (0.21%), Essex Investment Management Co. LLC (0.13%), DNB Asset Management AS (0.12%) and Conestoga Capital Advisors LLC (0.11%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich. View institutional ownership trends. How do I buy shares of Cryoport? Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cryoport's stock price today? One share of CYRX stock can currently be purchased for approximately $25.24. How much money does Cryoport make? Cryoport (NASDAQ:CYRX) has a market capitalization of $1.24 billion and generates $222.61 million in revenue each year. The consumer goods maker earns $-275,530,000.00 in net income (profit) each year or ($6.15) on an earnings per share basis. How many employees does Cryoport have? The company employs 791 workers across the globe. How can I contact Cryoport? Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306. This page (NASDAQ:CYRX) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.